Leading pathology's technology transformation - Insights
As chair of Mayo Clinic’s new Division of Computational Pathology and AI in the Department of Laboratory Medicine and Pathology, Jason Hipp, M.D., Ph.D., is eager to employ the most innovative tools available to benefit patients around the...
Check out how Mayo Clinic Laboratories’ digital pathology initiative integrates digital infrastructure to deliver digital workflows for patients to improve overall care.
NGS Testing for Neuro-Oncology - Mayo Clinic Laboratories
Mayo Clinic is recognized worldwide for providing care for complex diseases including brain tumors. With rapid technological advancements and medical discoveries, the standard approach to genetic testing is evolving.
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the use of qualitative urine screening assays and quantitative confirmatory testing to determine compliance in pain management patients.
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...
Part II of this series shows how a breakthrough discovery about how kidney stones form may open the way for new, unorthodox treatments. The discovery was made possible by joining University of Illinois’ geology and biology forces with Mayo...
Specialized testing helps reverse effects of stiff-person syndrome: James Kypuros - Insights
One summer morning, James Kypuros awoke to find his toes stiffened like claws. Then he started having falls, which culminated in losing his ability to walk or even sit up without help. Diagnosed with stiff-person syndrome, James wouldn’t...
Controlled substance monitoring - Insights
The Clinical and Forensic Toxicology Laboratory at Mayo Clinic offers the industry’s most comprehensive evidence-based urine drug testing menu to evaluate for the presence of controlled substances.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Our renal diagnostics are backed by a multidisciplinary approach and an award-winning team of Mayo Clinic nephrology experts, pathologists, and laboratory scientists who work at the intersection of research and patient care.